- Membership & Community
-
Publications & News
- Physiology Journals
-
Newsroom
-
The Physiologist Magazine
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
-
In Depth
- In Depth—The Bear Necessities
- In Depth: Understanding Circadian Rhythms
- In Depth: Understanding Data
- In Depth: Exercise Physiology: Take Your Medicine at the Gym
- In Depth: Neurodegenerative Disorders
- Imaging Methods Unveil the Invisible
- Rewiring the Brain: Breakthroughs in Neural Therapy
- What’s Coming Next for GLP-1 and Metabolic Disease Treatment
- Understanding the Effects of Maternal Exercise
-
Mentoring Forum
- Net Worth
- Take Care
- You … In Charge
- Work. It. Out.
- Working Off-site
- Location, Location, Location?
- Student Support
- Progressing to Postdoc
- Relationship Building
- Let’s Get It Started
- What Do We Value?
- It’s a Postdoc Life
- Coronavirus Contributions
- Creative Communications
- Selection Process
- Conference Connections
- Postdoc Appreciation
- Research Rewards
- Focus on Teaching
- Industry Insights
- Balance Beam
- Post Postdoc
- If You Build It
- Talk It Through
- Forward Bound
- I’ve Earned My PhD. Now What?
- University Life
- Tips for Trainees
- Time Travel
- Prepare Now for the Career You Want
- Landing a Postdoctoral Researcher Position
- Becoming a Physician-Scientist
- Mastering the Art of Science Communication
- Setting Yourself Up for Success in the Lab
- From Postdoc to Professor: Key Strategies for Success
- How to Stay Motivated in Challenging Times
- Staying Motivated Throughout Your Science Career
-
Policy IQ
- Policy IQ—2023 in Review: How APS Advocated on Behalf of Physiologists
- Policy IQ—Supporting Equitable Research
- NIH's Road Map to a Better Postdoc Experience
- The Career Path to Science Advocacy
- Culture of Safety: Stopping Sexual Misconduct
- Physiologists Return to Capitol Hill
- Tips for Scientists to Communicate about Animal Research
- Science Advocacy in a New Political Landscape
- Tips for Making the Call to Congress
- Science Spending Is an Investment
-
Publish with Polish
- Publish with Polish
- The Layers of Open Science
- Take Your Content From Meeting to Manuscript
- APS Journals to Highlight Women’s Health Research
- What Subscribe to Open Means for APS Members
- The 5 Pillars of Publish with Purpose
- 3 Types of Metadata Researchers Should Know About
- Navigating Open Access and New Licensing Options
- Journal Manuscript Prep Made Easy
- How to Navigate Public Access Requirements
- Under the Microscope
- Mentoring Q&A
- Evolution
- Baseline by Scott Steen, CAE, FASAE
- 2025
- Find Us on Social Media
-
The Physiologist Magazine
-
Professional Development
-
Meetings & Events
-
American Physiology Summit
- #APS2024 Overview
- Abstracts
- Awards at the Summit
- Award Lectures
- Career Networking Lunch Form
- Dates and Deadlines
- Advocate for Health Research Funding
- Hotel Information
- Information for International Travelers
- Industry Partners
- Keynote Speaker—James Rothman, PhD
- Keynote Speaker—George Brooks, PhD, FAPS
- Keynote Speaker—Holly Ingraham, PhD
- Mobile App
- NIH and NSF Program Officer Panel Discussion Form
- Physical Poster Information
- PhysioHub
- Pre-Summit Events
- Registration
- Section & Group Banquet Tickets
- Social Events
- Speaker Audiovisual Instructions
- Summit FAQs
- Summit Newsroom
- Travel & Transportation
- Undergraduate Program Book
- Liability Waiver
- Industry Partners
- 2026 American Physiology Summit
- Joseph Erlanger: Pioneering Nerve Research and APS Leadership
- 2023
- 2024
- Scientific Integrity Policy
- Exhibitor Registration Form
- New Trends in Sex Differences and Women’s Health Research
- Control of Renal Function in Health and Disease 2026
- Comparative Physiology Conference 2026
- Webinars
- Related Meetings
- Future APS Conferences
- Conference Policies
-
American Physiology Summit
- APS Awards
-
Career & Professional Development
-
Career Gateway
-
Resources
- Transcript—Leading Through Conflict and Difficult Conversations
- Transcript—Managing Conflict with Colleagues
- Transcript—Leading a Team Through Conflict
- Transcript—Providing Difficult Feedback
- Transcript—Team Dynamics and Culture Primer
- Transcript—Building a Team
- Transcript—Leading a Team Assigned to You
- Transcript—Creating a Team Culture
-
Resources
- Career Navigator
- Center for Physiology Education
- Virtual Courses
- Physiology Job Board
- APS Graduate Physiology & Biomedical Science Catalog
-
Career Gateway
-
Meetings & Events
-
Advocacy & Resources
- Policy Areas
-
Resources
- Researcher Resources
- Educator Resources
- Trainee Resources
- Student Resources
-
APS Graduate Physiology & Biomedical Science Catalog
- Des Moines University
- George Washington University
- Mayo Clinic Graduate School of Biomedical Sciences—Biomedical Engineering & Physiology
- Michigan State University
- New York Medical College
- Nova Southeastern University
- Pennsylvania State University
- Texas A&M University
- Texas A&M University Medical Physiology
- Stony Brook University
- The University of Iowa
- University of Alabama at Birmingham
- University at Buffalo
- University of Colorado
- University of Michigan
- University of Minnesota
- University of Missouri-Biomedical Sciences
- University of Nebraska Medical Center
- University of Nevada, Reno
- University of South Carolina School of Medicine
- University of Tennessee Health Science Center (UTHSC)
- University of Texas Health Science Center
- Virginia Commonwealth University
- Wayne State University
- Physiology Department Catalog Submission Form
- Boston University
- Women's Health Research Initiative
- Career Gateway
- Advocate for Science
- About APS
Review encourages medical personnel to develop personalized treatment based on patient’s pathophysiology
Rockville, Md. (June 11, 2020)—A new review details three distinct phases of COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, and urges medical professionals to consider an individualized treatment approach based on the disease phases and each patient’s symptoms. The review is published ahead of print in Physiological Reviews.
SARS-CoV-2, the novel coronavirus that causes COVID-19, is transmitted through droplets expelled from an infected person’s nose or mouth when they cough, sneeze or, in some cases, talk. Three distinct phases of COVID-19 infection have been observed in some people who test positive for the disease and have variable degrees of symptoms. Each phase is characterized by a different type of pathophysiological interaction with the virus.
During the early infection phase (Phase 1), the virus multiplies inside the body and is likely to cause mild symptoms that may be confused with a common cold or flu. The second phase is the pulmonary phase (Phase 2), when the immune system becomes strongly affected by infection and leads to primarily respiratory symptoms such as persistent cough, shortness of breath and low oxygen levels. Problems with blood clotting—especially with the formation of blood clots—may be predominant in Phase 2. The third, hyperinflammatory phase (Phase 3), occurs when a hyperactivated immune system may cause injury to the heart, kidneys and other organs. A “cytokine storm”—where the body attacks its own tissues—may occur in this phase. While there may be overlap among the three stages of disease, the review authors stress that it is crucial to recognize each stage in order to tailor treatment to the patient.
Many of the drugs used to treat people with COVID-19 are still being investigated for safety and effectiveness. The reviewers encourage researchers to evaluate these experimental treatments based on the specific disease phase they are being prescribed for, along with what is happening in the body as COVID-19 progresses. Drawing on experience treating patients in Italy, one of the hardest-hit countries during the earliest days of the pandemic, the researchers suggest medical professionals choose a personalized treatment plan with the following medications and treatments:
- Plasma containing antibodies from recovered COVID-19 patients (i.e., hyperimmune plasma), which has been found to reduce the amount of live virus (viral load) in the early infection phase.
- Antiviral drugs, including remdesivir, which have helped interrupt viral replication in Phase 1 and may continue to be beneficial in Phase 2.
- Tissue plasminogen activator (tPA). A drug used to treat stroke, tPA breaks up blood clots that may occur during Phase 2.
- Inflammation-fighting medications, including corticosteroids, tocilizumab and sarilumab. These may help reduce system-wide inflammation in Phases 2 and 3.
- The anticoagulant (anti-clotting drug) heparin is important during any stage of the disease to prevent blood clots in blood vessels and capillaries (micro- and macro-vascular thrombosis).
Although to date, there are no drugs proven to treat COVID-19, research is progressing rapidly. “We are now entering a new era of the pandemic, with many ongoing [randomized controlled trials] aimed at identifying patient-tailored drugs, and drugs better suited to the specific phase of the disease with improved precision,” the authors wrote. The scientific community is “making a tremendous effort to support an unprecedented number of pathophysiological studies and clinical trials to face this highly unexpected pandemic.”
Read the full article, “SARS-CoV-2 and COVID-19: between pathophysiology complexity and therapeutic uncertainty,” published ahead of print in Physiological Reviews.
NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact the APS Communications Office or call 301.634.7314. Find more research highlights in our News Room.
Physiology is the study of how molecules, cells, tissues and organs function in health and disease. Established in 1887, the American Physiological Society (APS) was the first U.S. society in the biomedical sciences field. The Society represents 9,000 members and publishes 16 peer-reviewed journals with a worldwide readership.
Related Content
- Viewing a Hot Virtual Environment Helps the Body Cool Off During Exercise
- Combining Two Diabetes Drugs Helps Promote Weight Loss and Blood Sugar Control
- Heat Really Does Feel Hotter After a Cold Season
- Hot Water Immersion Better than Cold to Maintain Exercise Performance
- Wolfgang Kuebler Receives American Physiological Society’s Presidential Service Award at American Physiology Summit
- Pre-Workout Beetroot Juice Improves Fitness Gains in Late Postmenopausal Women
- How Does She Run So Fast? Examining the Muscle Composition of a 91-Year-Old World Record Sprinter
Contact Us
Journalists may contact APS Communications to:
- Interview an expert
- Request a copy of a study
- Get physiology background and resources
Email: communications@physiology.org or call 301.634.7314.